VIRP 📈 Virbac SA - Overview

Virbac SA is a global animal health company that develops, manufactures, and distributes a wide range of products and services for both companion animals and farm animals. Its product portfolio encompasses various categories, including vaccines, dental hygiene products, reproduction and dermatology solutions, parasiticides, diagnostic tools, antibiotics, and aquaculture products. Additionally, the company offers veterinary medicines for specific applications such as anesthesia, geriatrics, behavior modification, and injectable micronutrients. Its offerings also extend to pet food and electronic identification systems, catering to the diverse needs of veterinarians, farmers, and pet owners across different regions.

With operations spanning multiple continents, including France, Europe, Latin America, North America, Asia, the Pacific, Africa, and the Middle East, Virbac SA has established itself as a significant player in the global animal health industry. Founded in 1968 and headquartered in Carros, France, the company has a long history of innovation and commitment to improving animal health and well-being. Its products and services are designed to address the health needs of animals, from prevention and diagnosis to treatment and nutrition, making it a comprehensive solution provider for the animal health sector.

Virbac SA's business is structured to serve various customer segments, including veterinarians, farmers, and pet owners, each with unique needs and requirements. The company's extensive distribution network and strategic partnerships enable it to reach a wide customer base, providing access to its products and services in different parts of the world. As a publicly traded company with its common stock listed under the ISIN code FR0000031577 and classified under the GICS Sub Industry: Pharmaceuticals, Virbac SA is committed to transparency, accountability, and delivering value to its shareholders while pursuing its mission to improve animal health and well-being globally.